M. Mealiffe

发表

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review

C. D. del Rio, J. Edelberg, A. Sehnert, 2022, American Journal of Cardiovascular Drugs.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.

S. Solomon, T. Wong, R. Bach, 2020, Journal of the American College of Cardiology.

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis

J. S. San Martin, R. Lachmann, H. Cheong, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.

L. Terstappen, T. Lane, P. Law, 1995, Blood.

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review

C. D. del Rio, J. Edelberg, A. Sehnert, 2022, American Journal of Cardiovascular Drugs.

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial

J. S. San Martin, F. Rauch, T. Kubota, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial.

C. Hendriksz, R. Giugliani, D. Hughes, 2015, Molecular genetics and metabolism.

Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas.

Cynthia C Morton, C. Morton, A. Ligon, 2005, American journal of human genetics.

Neutrophil elastase in cyclic and severe congenital neutropenia.

Stephen J Salipante, Zhijun Duan, Hu-Hui Lee, 2007, Blood.

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells

K. Offit, M. Tucker, T. Kirchhoff, 2009, Proceedings of the National Academy of Sciences.

Morquio A Syndrome-Associated Mutations: A Review of Alterations in the GALNS Gene and a New Locus-Specific Database

T. Oron, S. Mooney, A. Morrone, 2014, Human mutation.

Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

David A. Hinds, Ross L. Prentice, R. Stokowski, 2010, Journal of the National Cancer Institute.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

R. Eastell, J. S. San Martin, S. Ralston, 2019, Calcified Tissue International.

A Phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of Burosumab, an anti-FGF23 antibody, in adult X-Linked Hypophosphatemia (XLH)

R. Eastell, S. Ralston, M. Brandi, 2018 .

Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

R. Stokowski, D. Hinds, R. Prentice, 2010, Journal of the National Cancer Institute.